Northwestern University (T Weeden, R Garofalo, AK Johnson, and LM Kuhns), Department of Pediatrics, Feinberg School of Medicine, Chicago, Ill; Ann & Robert H. Lurie Children's Hospital of Chicago (T Weeden, R Garofalo, AK Johnson, M Cervantes, and LM Kuhns), Potocsnak Family Division of Adolescent and Young Adult Medicine, Chicago, Ill.
School of Nursing (R Schnall), Columbia University, New York City, NY.
Acad Pediatr. 2024 Sep-Oct;24(7):1110-1115. doi: 10.1016/j.acap.2024.04.005. Epub 2024 Apr 15.
Oral pre-exposure prophylaxis (PrEP) is effective in preventing HIV transmission. However, oral PrEP uptake is low, particularly among sexual and gender minority youth who are vulnerable to HIV infection. Alternative methods of PrEP delivery, such as long-acting injectable (LAI) PrEP may overcome barriers and be preferred. However, attitudes and preferences of younger sexual and gender minorities towards LAI PrEP have not been well studied. The purpose of this study is to describe preferences for initiating LAI PrEP among sexual and gender minority youth.
We analyzed data collected as part of an HIV prevention randomized trial from January 2022 to February 2023, using multiple regression to identify factors associated with a preference for LAI PrEP.
The study sample (N = 265) was 50% youth of color, mean age 25 years (SD=3.4, range=18-31), and primarily identified as gay (71%) and male (91%). Forty two percent had heard of LAI PrEP and 31% preferred LAI PrEP over other prevention methods. In multiple regression analysis, LAI PrEP preference was associated with identifying as White, previous PrEP experience, and perceived LAI PrEP efficacy.
We conclude that gaps in awareness exist for LAI PrEP, however it may be preferred over other prevention methods especially in White youth, those with PrEP experience and higher perceptions of its efficacy. More education and outreach are needed to prevent extension of existing race and ethnicity disparities in use of oral daily PrEP to LAI PrEP.
口服暴露前预防(PrEP)在预防 HIV 传播方面非常有效。然而,口服 PrEP 的使用率很低,特别是在易感染 HIV 的性少数群体和性别少数群体青年中。替代 PrEP 给药方法,如长效注射(LAI)PrEP,可能会克服障碍并更受欢迎。然而,年轻的性少数群体和性别少数群体对 LAI PrEP 的态度和偏好尚未得到充分研究。本研究的目的是描述性少数群体和性别少数群体青年开始使用 LAI PrEP 的偏好。
我们分析了 2022 年 1 月至 2023 年 2 月期间作为 HIV 预防随机试验的一部分收集的数据,使用多元回归分析确定与 LAI PrEP 偏好相关的因素。
研究样本(N=265)中 50%为有色人种青年,平均年龄 25 岁(SD=3.4,范围 18-31),主要自认为是同性恋(71%)和男性(91%)。42%的人听说过 LAI PrEP,31%的人更喜欢 LAI PrEP 而不是其他预防方法。在多元回归分析中,LAI PrEP 偏好与自我认同为白人、之前使用过 PrEP 以及认为 LAI PrEP 有效相关。
我们得出结论,LAI PrEP 的认知存在差距,但它可能比其他预防方法更受欢迎,特别是在白人青年、有 PrEP 经验和更高的 LAI PrEP 疗效认知的人群中。需要进一步开展教育和宣传,以防止在口服每日 PrEP 向 LAI PrEP 的使用方面扩大现有的种族和族裔差异。